No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs10863785 |
chr1:209908876-209908877 |
Weak transcription Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs543364033 |
chr1:209908877-209908878 |
Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs12123431 |
chr1:209908899-209908900 |
Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs569255314 |
chr1:209908946-209908947 |
Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs537815967 |
chr1:209909003-209909004 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs528880470 |
chr1:209909004-209909005 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs566803144 |
chr1:209909060-209909061 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs150870355 |
chr1:209909093-209909094 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs139373402 |
chr1:209909137-209909138 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs145645426 |
chr1:209909166-209909167 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs147756323 |
chr1:209909186-209909187 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs559456683 |
chr1:209909201-209909202 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs142341274 |
chr1:209909208-209909209 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs549425274 |
chr1:209909253-209909254 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs190602301 |
chr1:209909254-209909255 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs374063402 |
chr1:209909258-209909259 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs367872132 |
chr1:209909314-209909315 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs115516780 |
chr1:209909318-209909319 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs558434294 |
chr1:209909355-209909356 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs2064148 |
chr1:209909385-209909386 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
21 |
rs80337405 |
chr1:209909409-209909410 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs78059492 |
chr1:209909422-209909423 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs115145015 |
chr1:209909433-209909434 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs111488558 |
chr1:209909509-209909510 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs543675340 |
chr1:209909522-209909523 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs116687539 |
chr1:209909569-209909570 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs573286740 |
chr1:209909572-209909573 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs540666110 |
chr1:209909627-209909628 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs117538664 |
chr1:209909674-209909675 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs553933227 |
chr1:209909679-209909680 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs144574791 |
chr1:209909708-209909709 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs574457594 |
chr1:209909710-209909711 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs563869770 |
chr1:209909728-209909729 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs541549838 |
chr1:209909811-209909812 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs531032592 |
chr1:209909842-209909843 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs549628109 |
chr1:209909858-209909859 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs183174637 |
chr1:209909860-209909861 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs189210202 |
chr1:209909873-209909874 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs370728806 |
chr1:209909874-209909875 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs192301296 |
chr1:209909914-209909915 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs375345042 |
chr1:209909927-209909928 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs182862884 |
chr1:209910112-209910113 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs575206213 |
chr1:209910195-209910196 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs113353370 |
chr1:209910263-209910264 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs539091457 |
chr1:209910286-209910287 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs541765649 |
chr1:209910312-209910313 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs145715013 |
chr1:209910347-209910348 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs543816194 |
chr1:209910383-209910384 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs148946907 |
chr1:209910384-209910385 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs143723245 |
chr1:209910404-209910405 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|